SynOV1.1

AXP000045.1 · Oncolytic virus

Platform
adenovirus (Ad5, AFP-responsive synthetic gene circuit)
Originator
Beijing Syngentech
Sponsor
Beijing Syngentech

Names

NameTypeSource
SynOV1.1preferred name, codecurator, ncit

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 (SynOV1.1)
Replication
conditionally replicating
Modifications
synthetic gene circuit restricting replication and transgene expression to AFP-positive cells
Transgenes
CSF2
Route
intratumoral
Source
evidence

Cross-references

NCI Thesaurus
C179256

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT04612504SynOV1.1 Intratumoral Injection StudyUnknownPhase 12022-06-232023-12-3015Hepatocellular Carcinoma

Recent changes

No changes recorded in its trials yet.

Notes

Oncolytic adenovirus with a synthetic gene circuit that restricts replication and GM-CSF expression to alpha-fetoprotein-positive cancer cells. Phase I NCT04612504 in AFP-positive hepatocellular carcinoma.

How to cite

SynOV1.1 (AXP000045.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000045.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.